REDWOOD CITY, Calif.--(

加利福尼亚州红木市--(

BUSINESS WIRE

商业热线

)--

)--

Prenuvo

普雷努沃

, the leader in proactive whole-body MRI screening, today disclosed that it quietly raised $120M as part of Series B fundraising during 2024, demonstrating its category leadership in preventative health. The company has identified over 1.4 million personalized health insights across its member base, highlighting the critical role of early detection.

作为主动全身MRI筛查的领导者，今天透露，作为2024年B系列筹款的一部分，该公司悄悄筹集了1.2亿美元，证明了其在预防性健康领域的领先地位。该公司在其成员群体中发现了140多万个个性化健康见解，突出了早期发现的关键作用。

This milestone comes as Prenuvo surpassed 110,000 members and secured FDA clearance for its AI-powered Prenuvo Body Composition report..

这是一个里程碑，因为Prenuvo超过了110000名成员，并获得了FDA批准其人工智能驱动的Prenuvo身体成分报告。。

“Prenuvo is leading a movement to make proactive healthcare accessible and transformative for everyone,” said Andrew Lacy, CEO of Prenuvo Inc. “We’re introducing a new approach to early detection that empowers individuals to take control of their health before symptoms emerge. This isn’t just about healthcare; it’s about reimagining how we approach health, using cutting-edge technology and world-class expertise to prevent disease and help people live longer, healthier lives.”.

Prenuvo Inc.首席执行官安德鲁·莱西（AndrewLacy）表示：“Prenuvo正在领导一场运动，让每个人都能获得积极主动的医疗保健服务，实现变革。我们正在引入一种新的早期检测方法，使个人能够在症状出现之前控制自己的健康。这不仅仅是关于医疗保健，而是关于重新想象我们如何对待健康，利用尖端技术和世界一流的专业知识来预防疾病，帮助人们过上更长、更健康的生活。”。

The round, co-led by Forerunner Ventures, Left Lane Capital, and existing investor Felicis, has accelerated Prenuvo’s augmentation of its core industry-leading whole-body MRI screening with additional modalities and analyses of the human body.

这一轮由先驱风险投资公司、Left Lane Capital和现有投资者Felicis共同领导，加速了Prenuvo通过额外的人体模式和分析来增强其核心行业领先的全身MRI筛查。

Innovative Product Expansion

创新产品扩展

Prenuvo today announced FDA clearance for its AI-powered Prenuvo Body Composition report, marking a significant milestone in the company’s growth. Building on this momentum, Prenuvo introduces three major advances:

Prenuvo今天宣布FDA批准其人工智能Prenuvo身体成分报告，这标志着该公司发展的一个重要里程碑。在这一势头的基础上，Prenuvo推出了三大进步：

FDA-cleared, AI-powered whole-body composition analysis platform

FDA批准的人工智能全身成分分析平台

that is non-invasive and delivers precise, actionable, and quantitative data on visceral fat, subcutaneous fat, liver fat, muscle volumes, as well as the volume of vital abdominal organs – providing patients with a personalized report to make informed lifestyle choices and proactive health decisions..

这是非侵入性的，可提供有关内脏脂肪，皮下脂肪，肝脏脂肪，肌肉体积以及重要腹部器官体积的精确，可行和定量数据，为患者提供个性化报告，以做出明智的生活方式选择和积极的健康决策。。

Groundbreaking new brain health scan

开创性的新脑部健康扫描

that equips patients with critical data on brain function, cognitive health, and early indicators of neurodegenerative conditions.

这为患者提供了有关大脑功能，认知健康和神经退行性疾病早期指标的关键数据。

Comprehensive functional and conventional blood bio-marker assessment

全面的功能和常规血液生物标志物评估

that uses a custom built panel of blood tests to provide insights into metabolic, cardiovascular, hormonal, and immune health. Designed to work symbiotically with imaging to deepen health insights.

。旨在与成像协同工作，深化健康见解。

These new capabilities will launch immediately in a bundled offering called Prenuvo Enhanced in Silicon Valley, Los Angeles and New York locations, with other locations offering these enhanced screenings in the spring. To sign up for a waitlisted location, visit

这些新功能将立即在硅谷、洛杉矶和纽约地区推出名为Prenuvo Enhanced的捆绑产品，其他地区将在春季提供这些增强的屏幕。要注册等待名单上的地点，请访问

https://prenuvo.com/enhanced-screening

https://prenuvo.com/enhanced-screening

“Last year demonstrated an unmistakable shift in consumer behavior towards proactive health management,” said Sundeep Peechu, Managing Partner at Felicis. “Prenuvo has a unique integrated model that is difficult to replicate, and their advanced screening positions them to lead this transformation in preventative healthcare.”.

。“Prenuvo有一个独特的综合模型，很难复制，他们的先进筛查使他们能够在预防保健领域引领这一转变。”。

Deliberate Growth and Clinical Excellence

刻意成长和临床卓越

Prenuvo has built the world’s largest private radiology group focused solely on whole-body MRI, with over 80 board-certified radiologists. This expertise has driven research collaborations with premier academic centers studying health, aging, and disease through the unique combination of MRI and AI..

Prenuvo建立了世界上最大的私人放射学集团，专注于全身MRI，拥有80多名董事会认证的放射科医生。这种专业知识通过MRI和AI的独特组合，推动了与研究健康，衰老和疾病的顶级学术中心的研究合作。。

Unlike others who outsource both imaging and radiology services, Prenuvo is fully vertically integrated, owning and operating 17 dedicated centers across North America. With a growing movement to prioritize preventative healthcare, Prenuvo will bring its revolutionary approach to 15 more clinics, including Europe and Australia, marking its first international expansion outside of North America..

与其他外包成像和放射服务的公司不同，Prenuvo完全垂直整合，在北美拥有并运营17个专用中心。随着越来越多的运动将预防保健列为优先事项，Prenuvo将为包括欧洲和澳大利亚在内的另外15家诊所带来革命性的方法，这标志着其首次在北美以外的国际扩张。。

“With only 2.5% of healthcare spending focused on preventative medicine, the US system waits for people to become sick before intervening,” said Brian O’Malley from Forerunner. “Consumers have grown tired of this and are responding with their own wallets. Prenuvo is the preeminent solution for a comprehensive understanding of one’s health, giving today’s patients unprecedented levels of knowledge to not just understand, but proactively intervene in the challenges that arise as we all age.

Forefunner公司的布莱恩·奥马利（BrianO'Malley）表示：“由于只有2.5%的医疗保健支出集中在预防性药物上，美国系统会等到人们生病后再进行干预。”。“消费者已经厌倦了这一点，并用自己的钱包做出回应。Prenuvo是全面了解健康的卓越解决方案，为当今的患者提供了前所未有的知识水平，不仅可以理解，而且可以主动干预随着年龄的增长而出现的挑战。

Longevity is the new luxury and Prenuvo is democratizing access so that more can benefit from this.”.

长寿是一种新的奢侈品，Prenuvo正在使获取途径民主化，以便更多人可以从中受益。”。

“Prenuvo has empowered patients in ways that conventional medical care simply hasn’t. Consumers are taking ownership and seeking answers outside of the traditional healthcare system. The physician and clinical ecosystem is waking up to the needs and wants of their patients, who are increasingly demanding proactive and preventative healthcare solutions like Prenuvo,” says Harley Miller, Managing Partner & CEO, Left Lane Capital.

Left Lane Capital管理合伙人兼首席执行官哈雷·米勒（Harley Miller）表示：“Prenuvo以传统医疗护理无法做到的方式赋予患者权力。消费者正在拥有所有权，并在传统医疗体系之外寻求答案。医生和临床生态系统正在意识到患者的需求和愿望，他们越来越需要像Prenuvo这样的主动预防性医疗解决方案。”。

“We look forward to seeing how the team continues to scale, advance their proprietary research, and build on their life-changing (and saving) technology.”.

“我们期待着看到该团队如何继续扩大规模，推进其专有研究，并建立在改变生命（和拯救生命）的技术之上。”。

About Prenuvo

关于普雷努沃

Prenuvo makes MRI scanning for early detection of many types of cancer, “silent killers” like aneurysms, and other diseases seamless and more widely accessible. Combining cutting-edge analysis technology with radiation-free and non-invasive full-body scans, Prenuvo’s patient-centric design is optimized to assess the body holistically and in under 60 minutes, compared with the several hours it would take to achieve this level of insight from conventional MRI scans.

Prenuvo使MRI扫描能够早期发现多种类型的癌症，如动脉瘤等“沉默杀手”以及其他无缝且更广泛的疾病。将尖端分析技术与无辐射和无创全身扫描相结合，Prenuvo以患者为中心的设计经过优化，可以在60分钟内全面评估身体，而传统MRI扫描需要几个小时才能达到这一水平。

Prenuvo, Inc. is the administrative and managerial services company for the affiliated Prenuvo physician-owned professional corporations that deliver medical services in-office and virtually. Prenuvo Inc. and the Prenuvo medical entities do business under the “Prenuvo” brand..

Prenuvo，Inc.是为附属Prenuvo医师拥有的专业公司提供行政和管理服务的公司，这些公司在办公室和虚拟环境中提供医疗服务。Prenuvo Inc.和Prenuvo医疗实体以“Prenuvo”品牌开展业务。。

Prenuvo is backed by leading venture capital firms and investors in health, fitness and category-defining consumer brands such as Felicis [investors in Fitbit (IPO), Guardant Health (IPO) and Ring (acq. by Amazon)], 23AndMe CEO Anne Wojcicki, Nest founder Tony Fadell, Eric Schmidt, Cindy Crawford and Lasker award recipient Dr.

Prenuvo得到了领先的风险投资公司和健康、健身和类别定义消费品牌投资者的支持，如Felicis[Fitbit（IPO）、Guardant health（IPO）和Ring（亚马逊acq）的投资者]，23AndMe首席执行官安妮·沃西基（AnneWojcicki），Nest创始人托尼·法德尔（TonyFadell），埃里克·施密特（EricSchmidt），辛迪·克劳福德（CindyCrawford）和拉斯克奖获得者Dr。

Timothy A. Springer..

蒂莫西·A·斯普林格。。

About Forerunner

关于先行者

Forerunner

先行者

is a venture capital firm investing at the intersection of shifting consumer behavior and emerging, transformative technology. Founded in 2012, Forerunner has raised nearly $3 billion in assets under management, and is an early investor in, Chime, Faire, OURA, Hims & Hers, The Farmer’s Dog, Ritual, Headway, Prenuvo, Fora, Glossier, and more..

是一家风险投资公司，投资于不断变化的消费者行为和新兴的变革性技术的交叉点。先行者成立于2012年，管理资产已筹集近30亿美元，是Chime、Faire、OURA、Hims＆Hers、The Farmer's Dog、Riture、Headway、Prenuvo、Fora、Glossier等的早期投资者。。

About Left Lane Capital

关于Left Lane Capital

Founded in 2019, Left Lane Capital is a New York and London-based global venture capital and growth equity firm investing in hyper-growth consumer and SMB businesses with enduring customer relationships. Left Lane's mission is to partner with extraordinary entrepreneurs who create category-defining companies across growth sectors of the economy.

Left Lane Capital成立于2019年，是一家总部位于纽约和伦敦的全球风险投资和成长股权公司，投资于具有持久客户关系的超增长消费者和中小企业。Left Lane的使命是与杰出的企业家合作，这些企业家在经济增长领域创建类别定义公司。

Select investments include Talkiatry, Evvy, Pearl, Wayflyer, M1 Finance, Bilt Rewards, Blank Street, Kings League, Olipop, and more..

精选投资包括Talkiatry、Evvy、Pearl、Wayflyer、M1 Finance、Bilt Rewards、Blank Street、Kings League、Olipop等。。

For more information, visit

有关更多信息，请访问

leftlane.com

网站 leftlane.com

.

.

About Felicis

关于Felicis

Founded in 2006, Felicis is a venture capital firm investing in companies reinventing core markets, as well as those creating frontier technologies. Felicis focuses on early-stage investments and currently manages over $3B in capital across 9 funds. The firm is an early backer of more than 50 companies valued at $1B+.

Felicis成立于2006年，是一家风险投资公司，投资于重塑核心市场的公司以及创造前沿技术的公司。Felicis专注于早期投资，目前管理着9只基金超过30亿美元的资本。。

More than 100 of its portfolio companies have been acquired or gone public, including Adyen (IPO), Credit Karma (acq by Intuit), Cruise (acq by General Motors), Fitbit (IPO), Guardant Health (IPO), Meraki (acq by Cisco), Ring (acq by Amazon), and Shopify (IPO). The firm is based in Menlo Park and San Francisco in California.

其100多家投资组合公司已被收购或上市，包括Adyen（IPO）、Credit Karma（Intuit的acq）、Cruise（通用汽车的acq）、Fitbit（IPO）、Guardant Health（IPO）、Meraki（思科的acq）、Ring（亚马逊的acq）和Shopify（IPO）。该公司总部位于加利福尼亚州的门洛帕克和旧金山。

Learn more at .

更多信息，请访问。

felicis.com

felicis.com

.

.